Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Joseph Lehar
SVP, R&D STRATEGY, OWKIN
PDUFA VII and Beyond: Building Confidence in AI Tools as New “Gold Standards” for Drug Development
Theodore (Ted) Lehman
PRINCIPAL, TODD STRATEGY GROUP
Intellectual Property Law in the 118th Congress
Washington, United States
Julianna LeMieux
DEPUTY EDITOR IN CHIEF, GENETIC ENGINEERING NEWS
Making the Dream of Synthetic Biology a Reality
Placeholder Photo
Peter Leonardi
CEO/CO-FOUNDER, OMNICYTE
OmniCyte
Lizabeth Leveille, MS
VP AND HEAD, BOSTON & EUROPEAN INNOVATION HUBS & DISCOVERY TRANSACTIONS, BD&L, MERCK
Merck
Cambridge, Massachusetts, United States
Andrew Levin, MD, PhD
PARTNER AND MANAGING DIRECTOR, RA CAPITAL MANAGEMENT
Healthy Returns: Healthspan Investment Comes of Age
Stephen Levy, PhD
FOUNDING PARTNER, CYTEQUEST
CyteQuest
Ithaca, New York, United States
Yuanpei Li, ACA
CEO, THERANOSTEC INC
Theranostec Inc
CARMICHAEL, California, United States
Cynthia Li, PhD
VP, BUSINESS AND CORPORATE DEVELOPMENT, SPOTLIGHT THERAPEUTICS
Platforms & Products: Creating Collaborations That Turn Technologies into Therapeutics
Placeholder Photo
Kun-Po Li
ASSOCIATE DIRECTOR OF EXTERNAL COLLABORATION AND CLINICAL DEVELOPMENT, IMMUNWORK, INC.
T-E Meds, Inc.